Health
Investors like what they see under Healthia's skin, boosting its value to $185m
Allied health company Healthia Limited (ASX: HLA) has almost doub...
Needle-phobes rejoice: NeedleCalm launches in Australia
An innovative piece of medical technology aimed at reducing physi...
Medibank profit rises, CEO Craig Drummond to depart
Private health insurance provider Medibank (ASX: MPL) has capital...
Starpharma's anti-COVID nasal spray approved in Europe and the UK
Australian pharmaceutical company Starpharma's (ASX: SPL) ant...
Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings
Mitigation measures against COVID-19 led to a drastic reduction i...
Advertisement
Latest News
John Poynton the latest Crown director to resign
The exodus of Crown Resorts' (ASX: CWN) board continues today...
Aussie startup GreaseBoss accepted into prestigious Y Combinator program
The founders of Australian lubrication management system startup ...
750,000 CommBank customers sent notice to join "junk" credit card class action
More than 750,000 Australians will receive notice from the Federa...
Investors like what they see under Healthia's skin, boosting its value to $185m
Allied health company Healthia Limited (ASX: HLA) has almost doub...
Consumer data platform Lexer lands $33m Series B to further international ambitions
Melbourne-based Lexer, a consumer data platform for brands and re...
Viva Leisure raises $30m to pump up as gym junkies return in droves
As gym junkies return in droves to its centres, Viva Leisure (ASX: ...
Mesoblast, Novartis sign commercialisation deal for COVID-19 treatment
Australian pharmaceutical company Mesoblast (ASX: MSB) has penned...
Pfizer COVID-19 vaccine now 95 per cent effective
A COVID-19 vaccine candidate being developed by US pharmaceutical...
Althea gets green light to sell Australian-made medicinal cannabis in Germany
Melbourne-based Althea Group (ASX: AGH) is on track to becoming t...
Class action "the only hope" for Smiles Inclusive partners on the sidelines
Smiles Inclusive (ASX: SIL) joint venture partners (JVPs) have ha...
CSL to build $800m flu vaccine facility in Melbourne
Australia-headquartered CSL (ASX: CSL) is set to bring a cell-bas...
UQ COVID-19 vaccine "ahead of schedule", Phase 3 trials to commence soon
A COVID-19 vaccine being developed by the University of Queenslan...
Restrictions on ACT venues to ease tomorrow, patron cap will increase to 500
The improving COVID-19 situation in Victoria and New South Wales ...
Mesoblast rebounds on COVID-19 treatment update, puts vaccine concerns to bed
Melbourne-based med-tech company Mesoblast (ASX: MSB) has rebound...
Health fund backs medicinal cannabis with Little Green Pharma deal
Little Green Pharma (ASX: LGP) hopes a new strategic partnership ...
Smiles Inclusive enters voluntary administration
The local anaesthetic of turnaround promises has finally wor...
MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m
Medical software group MedAdvisor (ASX: MDR) is prepared to ...
Healthia to buy The Optical Company for $43 million
Just one day after announcing yet another spending spree, allied ...
Atomo's COVID-19 nasal swab test gets green light from TGA
Sydney-based Atomo Diagnostics (ASX: AT1) has yet another feather...
Noxopharm starts trial in COVID-19 treatment race
Burgeoning medtech company Noxopharm (ASX: NOX) is making strides...
Advertisement
Partner Content
It's fair to say that at the start of 2020, few would have pr...
Momentum for cannabis stocks continues to intensify, as internati...
ESG (Environment, Social, Governance) has become essential in bus...
While some prefer to invest their money in stocks, bonds or prope...
If intellectual property (IP) is what differentiates a business f...
The COVID-19 pandemic has fundamentally changed the way Australia...
Curtin University and Extreme Tech Challenge (XTC) have partnere...
Due diligence is paramount for responsible lending, but that does...
After seeing how expensive and time-consuming it was for the mili...
Upskilling was the name of the game when energy specialist Jessie...
Advertisement